Is the Market Going to Go Lower?
The last month has been extremely difficult for the stock…
Sell
47
BIB Quote, Financials, Valuation and Earnings
Last price:
$53.08
Seasonality move
:
5.18%
Day range:
$53.07 - $54.85
52-week range:
$47.20 - $69.56
Dividend yield:
1.56%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
3.9K
Avg. volume:
10.2K
1-year change:
-2.37%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
BIB
ProShares Ultra Nasdaq Biotechnology
|
-- | -- | -- | -- | -- |
|
DRN
Direxion Daily Real Estate Bull 3X Shares
|
-- | -- | -- | -- | -- |
|
HIBL
Direxion Daily S&P 500 High Beta Bull 3X Shares
|
-- | -- | -- | -- | -- |
|
TPOR
Direxion Daily Transportation Bull 3X Shares
|
-- | -- | -- | -- | -- |
|
URE
ProShares Ultra Real Estate
|
-- | -- | -- | -- | -- |
|
UYM
ProShares Ultra Materials
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
BIB
ProShares Ultra Nasdaq Biotechnology
|
$54.71 | -- | -- | -- | $0.40 | 1.56% | -- |
|
DRN
Direxion Daily Real Estate Bull 3X Shares
|
$10.50 | -- | -- | -- | $0.04 | 2.1% | -- |
|
HIBL
Direxion Daily S&P 500 High Beta Bull 3X Shares
|
$31.73 | -- | -- | -- | $0.07 | 1.44% | -- |
|
TPOR
Direxion Daily Transportation Bull 3X Shares
|
$25.37 | -- | -- | -- | $0.06 | 1.66% | -- |
|
URE
ProShares Ultra Real Estate
|
$66.12 | -- | -- | -- | $0.42 | 1.97% | -- |
|
UYM
ProShares Ultra Materials
|
$23.98 | -- | -- | -- | $0.08 | 0.93% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
BIB
ProShares Ultra Nasdaq Biotechnology
|
-- | 1.913 | -- | -- |
|
DRN
Direxion Daily Real Estate Bull 3X Shares
|
-- | 3.604 | -- | -- |
|
HIBL
Direxion Daily S&P 500 High Beta Bull 3X Shares
|
-- | 3.770 | -- | -- |
|
TPOR
Direxion Daily Transportation Bull 3X Shares
|
-- | 3.760 | -- | -- |
|
URE
ProShares Ultra Real Estate
|
-- | 2.467 | -- | -- |
|
UYM
ProShares Ultra Materials
|
-- | 2.034 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
BIB
ProShares Ultra Nasdaq Biotechnology
|
-- | -- | -- | -- | -- | -- |
|
DRN
Direxion Daily Real Estate Bull 3X Shares
|
-- | -- | -- | -- | -- | -- |
|
HIBL
Direxion Daily S&P 500 High Beta Bull 3X Shares
|
-- | -- | -- | -- | -- | -- |
|
TPOR
Direxion Daily Transportation Bull 3X Shares
|
-- | -- | -- | -- | -- | -- |
|
URE
ProShares Ultra Real Estate
|
-- | -- | -- | -- | -- | -- |
|
UYM
ProShares Ultra Materials
|
-- | -- | -- | -- | -- | -- |
ProShares Ultra Nasdaq Biotechnology vs. Competitors
-
Which has Higher Returns BIB or DRN?
Direxion Daily Real Estate Bull 3X Shares has a net margin of -- compared to ProShares Ultra Nasdaq Biotechnology's net margin of --. ProShares Ultra Nasdaq Biotechnology's return on equity of -- beat Direxion Daily Real Estate Bull 3X Shares's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital BIBProShares Ultra Nasdaq Biotechnology-- -- -- DRNDirexion Daily Real Estate Bull 3X Shares-- -- -- -
What do Analysts Say About BIB or DRN?
ProShares Ultra Nasdaq Biotechnology has a consensus price target of --, signalling downside risk potential of --. On the other hand Direxion Daily Real Estate Bull 3X Shares has an analysts' consensus of -- which suggests that it could fall by --. Given that ProShares Ultra Nasdaq Biotechnology has higher upside potential than Direxion Daily Real Estate Bull 3X Shares, analysts believe ProShares Ultra Nasdaq Biotechnology is more attractive than Direxion Daily Real Estate Bull 3X Shares.
Company Buy Ratings Hold Ratings Sell Ratings BIBProShares Ultra Nasdaq Biotechnology0 0 0 DRNDirexion Daily Real Estate Bull 3X Shares0 0 0 -
Is BIB or DRN More Risky?
ProShares Ultra Nasdaq Biotechnology has a beta of 1.435, which suggesting that the stock is 43.488% more volatile than S&P 500. In comparison Direxion Daily Real Estate Bull 3X Shares has a beta of 3.138, suggesting its more volatile than the S&P 500 by 213.839%.
-
Which is a Better Dividend Stock BIB or DRN?
ProShares Ultra Nasdaq Biotechnology has a quarterly dividend of $0.40 per share corresponding to a yield of 1.56%. Direxion Daily Real Estate Bull 3X Shares offers a yield of 2.1% to investors and pays a quarterly dividend of $0.04 per share. ProShares Ultra Nasdaq Biotechnology pays -- of its earnings as a dividend. Direxion Daily Real Estate Bull 3X Shares pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BIB or DRN?
ProShares Ultra Nasdaq Biotechnology quarterly revenues are --, which are smaller than Direxion Daily Real Estate Bull 3X Shares quarterly revenues of --. ProShares Ultra Nasdaq Biotechnology's net income of -- is lower than Direxion Daily Real Estate Bull 3X Shares's net income of --. Notably, ProShares Ultra Nasdaq Biotechnology's price-to-earnings ratio is -- while Direxion Daily Real Estate Bull 3X Shares's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for ProShares Ultra Nasdaq Biotechnology is -- versus -- for Direxion Daily Real Estate Bull 3X Shares. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BIBProShares Ultra Nasdaq Biotechnology-- -- -- -- DRNDirexion Daily Real Estate Bull 3X Shares-- -- -- --
-
Which has Higher Returns BIB or HIBL?
Direxion Daily S&P 500 High Beta Bull 3X Shares has a net margin of -- compared to ProShares Ultra Nasdaq Biotechnology's net margin of --. ProShares Ultra Nasdaq Biotechnology's return on equity of -- beat Direxion Daily S&P 500 High Beta Bull 3X Shares's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital BIBProShares Ultra Nasdaq Biotechnology-- -- -- HIBLDirexion Daily S&P 500 High Beta Bull 3X Shares-- -- -- -
What do Analysts Say About BIB or HIBL?
ProShares Ultra Nasdaq Biotechnology has a consensus price target of --, signalling downside risk potential of --. On the other hand Direxion Daily S&P 500 High Beta Bull 3X Shares has an analysts' consensus of -- which suggests that it could fall by --. Given that ProShares Ultra Nasdaq Biotechnology has higher upside potential than Direxion Daily S&P 500 High Beta Bull 3X Shares, analysts believe ProShares Ultra Nasdaq Biotechnology is more attractive than Direxion Daily S&P 500 High Beta Bull 3X Shares.
Company Buy Ratings Hold Ratings Sell Ratings BIBProShares Ultra Nasdaq Biotechnology0 0 0 HIBLDirexion Daily S&P 500 High Beta Bull 3X Shares0 0 0 -
Is BIB or HIBL More Risky?
ProShares Ultra Nasdaq Biotechnology has a beta of 1.435, which suggesting that the stock is 43.488% more volatile than S&P 500. In comparison Direxion Daily S&P 500 High Beta Bull 3X Shares has a beta of 4.473, suggesting its more volatile than the S&P 500 by 347.27%.
-
Which is a Better Dividend Stock BIB or HIBL?
ProShares Ultra Nasdaq Biotechnology has a quarterly dividend of $0.40 per share corresponding to a yield of 1.56%. Direxion Daily S&P 500 High Beta Bull 3X Shares offers a yield of 1.44% to investors and pays a quarterly dividend of $0.07 per share. ProShares Ultra Nasdaq Biotechnology pays -- of its earnings as a dividend. Direxion Daily S&P 500 High Beta Bull 3X Shares pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BIB or HIBL?
ProShares Ultra Nasdaq Biotechnology quarterly revenues are --, which are smaller than Direxion Daily S&P 500 High Beta Bull 3X Shares quarterly revenues of --. ProShares Ultra Nasdaq Biotechnology's net income of -- is lower than Direxion Daily S&P 500 High Beta Bull 3X Shares's net income of --. Notably, ProShares Ultra Nasdaq Biotechnology's price-to-earnings ratio is -- while Direxion Daily S&P 500 High Beta Bull 3X Shares's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for ProShares Ultra Nasdaq Biotechnology is -- versus -- for Direxion Daily S&P 500 High Beta Bull 3X Shares. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BIBProShares Ultra Nasdaq Biotechnology-- -- -- -- HIBLDirexion Daily S&P 500 High Beta Bull 3X Shares-- -- -- --
-
Which has Higher Returns BIB or TPOR?
Direxion Daily Transportation Bull 3X Shares has a net margin of -- compared to ProShares Ultra Nasdaq Biotechnology's net margin of --. ProShares Ultra Nasdaq Biotechnology's return on equity of -- beat Direxion Daily Transportation Bull 3X Shares's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital BIBProShares Ultra Nasdaq Biotechnology-- -- -- TPORDirexion Daily Transportation Bull 3X Shares-- -- -- -
What do Analysts Say About BIB or TPOR?
ProShares Ultra Nasdaq Biotechnology has a consensus price target of --, signalling downside risk potential of --. On the other hand Direxion Daily Transportation Bull 3X Shares has an analysts' consensus of -- which suggests that it could fall by --. Given that ProShares Ultra Nasdaq Biotechnology has higher upside potential than Direxion Daily Transportation Bull 3X Shares, analysts believe ProShares Ultra Nasdaq Biotechnology is more attractive than Direxion Daily Transportation Bull 3X Shares.
Company Buy Ratings Hold Ratings Sell Ratings BIBProShares Ultra Nasdaq Biotechnology0 0 0 TPORDirexion Daily Transportation Bull 3X Shares0 0 0 -
Is BIB or TPOR More Risky?
ProShares Ultra Nasdaq Biotechnology has a beta of 1.435, which suggesting that the stock is 43.488% more volatile than S&P 500. In comparison Direxion Daily Transportation Bull 3X Shares has a beta of 3.703, suggesting its more volatile than the S&P 500 by 270.347%.
-
Which is a Better Dividend Stock BIB or TPOR?
ProShares Ultra Nasdaq Biotechnology has a quarterly dividend of $0.40 per share corresponding to a yield of 1.56%. Direxion Daily Transportation Bull 3X Shares offers a yield of 1.66% to investors and pays a quarterly dividend of $0.06 per share. ProShares Ultra Nasdaq Biotechnology pays -- of its earnings as a dividend. Direxion Daily Transportation Bull 3X Shares pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BIB or TPOR?
ProShares Ultra Nasdaq Biotechnology quarterly revenues are --, which are smaller than Direxion Daily Transportation Bull 3X Shares quarterly revenues of --. ProShares Ultra Nasdaq Biotechnology's net income of -- is lower than Direxion Daily Transportation Bull 3X Shares's net income of --. Notably, ProShares Ultra Nasdaq Biotechnology's price-to-earnings ratio is -- while Direxion Daily Transportation Bull 3X Shares's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for ProShares Ultra Nasdaq Biotechnology is -- versus -- for Direxion Daily Transportation Bull 3X Shares. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BIBProShares Ultra Nasdaq Biotechnology-- -- -- -- TPORDirexion Daily Transportation Bull 3X Shares-- -- -- --
-
Which has Higher Returns BIB or URE?
ProShares Ultra Real Estate has a net margin of -- compared to ProShares Ultra Nasdaq Biotechnology's net margin of --. ProShares Ultra Nasdaq Biotechnology's return on equity of -- beat ProShares Ultra Real Estate's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital BIBProShares Ultra Nasdaq Biotechnology-- -- -- UREProShares Ultra Real Estate-- -- -- -
What do Analysts Say About BIB or URE?
ProShares Ultra Nasdaq Biotechnology has a consensus price target of --, signalling downside risk potential of --. On the other hand ProShares Ultra Real Estate has an analysts' consensus of -- which suggests that it could fall by --. Given that ProShares Ultra Nasdaq Biotechnology has higher upside potential than ProShares Ultra Real Estate, analysts believe ProShares Ultra Nasdaq Biotechnology is more attractive than ProShares Ultra Real Estate.
Company Buy Ratings Hold Ratings Sell Ratings BIBProShares Ultra Nasdaq Biotechnology0 0 0 UREProShares Ultra Real Estate0 0 0 -
Is BIB or URE More Risky?
ProShares Ultra Nasdaq Biotechnology has a beta of 1.435, which suggesting that the stock is 43.488% more volatile than S&P 500. In comparison ProShares Ultra Real Estate has a beta of 2.111, suggesting its more volatile than the S&P 500 by 111.137%.
-
Which is a Better Dividend Stock BIB or URE?
ProShares Ultra Nasdaq Biotechnology has a quarterly dividend of $0.40 per share corresponding to a yield of 1.56%. ProShares Ultra Real Estate offers a yield of 1.97% to investors and pays a quarterly dividend of $0.42 per share. ProShares Ultra Nasdaq Biotechnology pays -- of its earnings as a dividend. ProShares Ultra Real Estate pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BIB or URE?
ProShares Ultra Nasdaq Biotechnology quarterly revenues are --, which are smaller than ProShares Ultra Real Estate quarterly revenues of --. ProShares Ultra Nasdaq Biotechnology's net income of -- is lower than ProShares Ultra Real Estate's net income of --. Notably, ProShares Ultra Nasdaq Biotechnology's price-to-earnings ratio is -- while ProShares Ultra Real Estate's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for ProShares Ultra Nasdaq Biotechnology is -- versus -- for ProShares Ultra Real Estate. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BIBProShares Ultra Nasdaq Biotechnology-- -- -- -- UREProShares Ultra Real Estate-- -- -- --
-
Which has Higher Returns BIB or UYM?
ProShares Ultra Materials has a net margin of -- compared to ProShares Ultra Nasdaq Biotechnology's net margin of --. ProShares Ultra Nasdaq Biotechnology's return on equity of -- beat ProShares Ultra Materials's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital BIBProShares Ultra Nasdaq Biotechnology-- -- -- UYMProShares Ultra Materials-- -- -- -
What do Analysts Say About BIB or UYM?
ProShares Ultra Nasdaq Biotechnology has a consensus price target of --, signalling downside risk potential of --. On the other hand ProShares Ultra Materials has an analysts' consensus of -- which suggests that it could fall by --. Given that ProShares Ultra Nasdaq Biotechnology has higher upside potential than ProShares Ultra Materials, analysts believe ProShares Ultra Nasdaq Biotechnology is more attractive than ProShares Ultra Materials.
Company Buy Ratings Hold Ratings Sell Ratings BIBProShares Ultra Nasdaq Biotechnology0 0 0 UYMProShares Ultra Materials0 0 0 -
Is BIB or UYM More Risky?
ProShares Ultra Nasdaq Biotechnology has a beta of 1.435, which suggesting that the stock is 43.488% more volatile than S&P 500. In comparison ProShares Ultra Materials has a beta of 2.319, suggesting its more volatile than the S&P 500 by 131.94%.
-
Which is a Better Dividend Stock BIB or UYM?
ProShares Ultra Nasdaq Biotechnology has a quarterly dividend of $0.40 per share corresponding to a yield of 1.56%. ProShares Ultra Materials offers a yield of 0.93% to investors and pays a quarterly dividend of $0.08 per share. ProShares Ultra Nasdaq Biotechnology pays -- of its earnings as a dividend. ProShares Ultra Materials pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios BIB or UYM?
ProShares Ultra Nasdaq Biotechnology quarterly revenues are --, which are smaller than ProShares Ultra Materials quarterly revenues of --. ProShares Ultra Nasdaq Biotechnology's net income of -- is lower than ProShares Ultra Materials's net income of --. Notably, ProShares Ultra Nasdaq Biotechnology's price-to-earnings ratio is -- while ProShares Ultra Materials's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for ProShares Ultra Nasdaq Biotechnology is -- versus -- for ProShares Ultra Materials. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income BIBProShares Ultra Nasdaq Biotechnology-- -- -- -- UYMProShares Ultra Materials-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
2 Dividend Stocks to Buy in a Recession
While many economists and investors initially expected 2025 to be…
Is Ford Stock Undervalued Amid the EV Transition?
There is a lot going on in the electric vehicle…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
54
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 41x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Alerts
Buy
63
EXOD alert for Mar 18
Exodus Movement [EXOD] is down 3.96% over the past day.
Sell
45
MNPR alert for Mar 18
Monopar Therapeutics [MNPR] is up 1.99% over the past day.
Sell
47
CELH alert for Mar 18
Celsius Holdings [CELH] is up 1.37% over the past day.
